Transforming cancer care with electronically controlled beam energy

Compact, precise, and accessible proton therapy
through innovative LINAC technology

The LiGHT System Advantage

230 MeV Achieved

Maximum energy demonstrated at Daresbury Integration Site with modular compact LINAC technology and electronically controlled beam energy—no degraders required.

$300M Development Investment

Substantial R&D investment establishing proven technology platform ready for clinical deployment and global commercialization.

70% Cost Reduction

4 treatment rooms per site at approximately $85M total capital cost—roughly 30% of competing systems with 12–18 month installation time.

Future-Ready Clinical Platform

Hypofractionation protocols operational today, with FLASH radiotherapy capability via software upgrade—no hardware modifications required.

How The LiGHT System Works

LiGHT (Linac for Image Guided Hadron Therapy) represents a paradigm shift in proton therapy delivery.

Modular Compact LINAC: Side Coupled Tube Linac (SCDTL) and Coupled Cavity Linac (CCL) architecture delivers unprecedented compactness without sacrificing clinical capability.
Electronic Energy Tuning: Eliminates mechanical energy degraders, reducing proton loss and enabling rapid, precise energy selection for optimal dose conformity.
Integrated Systems: Radio Frequency Quadrupole (RFQ) proton source and Patient Positioning System (PPS) work seamlessly within a 4-room configuration.
Clinical Versatility: From standard fractionation to ultra-high dose rate FLASH therapy—all through software control.

Explore Full Technology

Addressing a Critical Global Need

$500B+

Global Oncology Market

~9,500

Treatment Room Shortfall

$129.6M

Annual Revenue per Site Example

Based on 4 rooms, 3 fractions/hour, 12-hour days, 300 days/year at $3,000 per fraction

Join us in making advanced cancer treatment accessible to patients worldwide.

Business Model